Medical Bioanalytics: Separation Techniques in Medical Diagnostics of Neurological Diseases and Disorders on Selected Examples

2021 ◽  
pp. 1-18
Author(s):  
Joanna Kałużna-Czaplińska ◽  
Angelina Rosiak ◽  
Paulina Gątarek
2020 ◽  
Vol 6 (1) ◽  
pp. 3 ◽  
Author(s):  
Maria Hepel

The field of nanomedicine has recently emerged as a product of the expansion of a range of nanotechnologies into biomedical science, pharmacology and clinical practice. Due to the unique properties of nanoparticles and the related nanostructures, their applications to medical diagnostics, imaging, controlled drug and gene delivery, monitoring of therapeutic outcomes, and aiding in medical interventions, provide a new perspective for challenging problems in such demanding issues as those involved in the treatment of cancer or debilitating neurological diseases. In this review, we evaluate the role and contributions that the applications of magnetic nanoparticles (MNPs) have made to various aspects of nanomedicine, including the newest magnetic particle imaging (MPI) technology allowing for outstanding spatial and temporal resolution that enables targeted contrast enhancement and real-time assistance during medical interventions. We also evaluate the applications of MNPs to the development of targeted drug delivery systems with magnetic field guidance/focusing and controlled drug release that mitigate chemotherapeutic drugs’ side effects and damage to healthy cells. These systems enable tackling of multiple drug resistance which develops in cancer cells during chemotherapeutic treatment. Furthermore, the progress in development of ROS- and heat-generating magnetic nanocarriers and magneto-mechanical cancer cell destruction, induced by an external magnetic field, is also discussed. The crucial roles of MNPs in the development of biosensors and microfluidic paper array devices (µPADs) for the detection of cancer biomarkers and circulating tumor cells (CTCs) are also assessed. Future challenges concerning the role and contributions of MNPs to the progress in nanomedicine have been outlined.


2019 ◽  
Vol 26 (1) ◽  
pp. 121-165 ◽  
Author(s):  
Agnieszka Chylewska ◽  
Małgorzata Ogryzek ◽  
Mariusz Makowski

Background:Analytical chemistry and biotechnology as an interdisciplinary fields of science have been developed during many years and are experiencing significant growth, to cover a wide range of microorganisms separation techniques and methods, utilized for medical therapeutic and diagnostic purposes. Currently scientific reports contribute by introducing electrophoretical and immunological methods and formation of devices applied in food protection (avoiding epidemiological diseases) and healthcare (safety ensuring in hospitals).Methods:Electrophoretic as well as nucleic-acid-based or specific immunological methods have contributed tremendously to the advance of analyses in recent three decades, particularly in relation to bacteria, viruses and fungi identifications, especially in medical in vitro diagnostics, as well as in environmental or food protection.Results:The paper presents the pathogen detection competitiveness of these methods against conventional ones, which are still too time consuming and also labor intensive. The review is presented in several parts following the current trends in improved pathogens separation and detection methods and their subsequent use in medical diagnosis.Discussion:Part one, consists of elemental knowledge about microorganisms as an introduction to their characterization: descriptions of divisions, sizes, membranes (cells) components. Second section includes the development, new technological and practical solution descriptions used in electrophoretical procedures during microbes analyses, with special attention paid to bio-samples analyses like blood, urine, lymph or wastewater. Third part covers biomolecular areas that have created a basis needed to identify the progress, limitations and challenges of nucleic-acid-based and immunological techniques discussed to emphasize the advantages of new separative techniques in selective fractionating of microorganisms.


2005 ◽  
Vol 4 (3) ◽  
pp. 139-139
Author(s):  
L METZ ◽  
V YONG

2005 ◽  
Vol 4 (3) ◽  
pp. 138-139 ◽  
Author(s):  
F BANDINI

2020 ◽  
Vol 78 (8) ◽  
pp. 494-500 ◽  
Author(s):  
Adalberto STUDART-NETO ◽  
Bruno Fukelmann GUEDES ◽  
Raphael de Luca e TUMA ◽  
Antonio Edvan CAMELO FILHO ◽  
Gabriel Taricani KUBOTA ◽  
...  

ABSTRACT Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with worse outcomes. Notwithstanding, the role of neurologists in COVID-19 is probably underrecognized. Objective: The aim of this study was to report the reasons for requesting neurological consultations by internists and intensivists in a COVID-19-dedicated hospital. Methods: This retrospective study was carried out at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil, a 900-bed COVID-19 dedicated center (including 300 intensive care unit beds). COVID-19 diagnosis was confirmed by SARS-CoV-2-RT-PCR in nasal swabs. All inpatient neurology consultations between March 23rd and May 23rd, 2020 were analyzed. Neurologists performed the neurological exam, assessed all available data to diagnose the neurological condition, and requested additional tests deemed necessary. Difficult diagnoses were established in consensus meetings. After diagnosis, neurologists were involved in the treatment. Results: Neurological consultations were requested for 89 out of 1,208 (7.4%) inpatient COVID admissions during that period. Main neurological diagnoses included: encephalopathy (44.4%), stroke (16.7%), previous neurological diseases (9.0%), seizures (9.0%), neuromuscular disorders (5.6%), other acute brain lesions (3.4%), and other mild nonspecific symptoms (11.2%). Conclusions: Most neurological consultations in a COVID-19-dedicated hospital were requested for severe conditions that could have an impact on the outcome. First-line doctors should be able to recognize neurological symptoms; neurologists are important members of the medical team in COVID-19 hospital care.


Vestnik MEI ◽  
2018 ◽  
Vol 5 (5) ◽  
pp. 128-138
Author(s):  
Mikhail N. Kramm ◽  
◽  
Galina V. Zhikhareva ◽  
Sergey A. Zhgoon ◽  
Nikolay О. Strelkov ◽  
...  
Keyword(s):  

2012 ◽  
Vol 57 (3) ◽  
pp. 829-835 ◽  
Author(s):  
Z. Głowacz ◽  
J. Kozik

The paper describes a procedure for automatic selection of symptoms accompanying the break in the synchronous motor armature winding coils. This procedure, called the feature selection, leads to choosing from a full set of features describing the problem, such a subset that would allow the best distinguishing between healthy and damaged states. As the features the spectra components amplitudes of the motor current signals were used. The full spectra of current signals are considered as the multidimensional feature spaces and their subspaces are tested. Particular subspaces are chosen with the aid of genetic algorithm and their goodness is tested using Mahalanobis distance measure. The algorithm searches for such a subspaces for which this distance is the greatest. The algorithm is very efficient and, as it was confirmed by research, leads to good results. The proposed technique is successfully applied in many other fields of science and technology, including medical diagnostics.


Sign in / Sign up

Export Citation Format

Share Document